SFC
BIIB icon

SYM Financial Corp’s Biogen BIIB Stock Holding History

SYM Financial Corp’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Buy
1,186
+36
+3% +$6.89K 0.02% 303
2026
Q1 		$211K Buy
+1,150
New +$212K 0.02% 301
2025
Q4 		– Sell
-1,695
Closed -$237K – 425
2025
Q3 		$237K Buy
+1,695
New +$229K 0.03% 268

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SYM Financial Corp's BIIB Position: Q2 2026 in Review

SYM Financial Corp increased its Biogen (BIIB) stake by 3.1% in Q2 2026, buying an estimated $6.89K and bringing the position to 1,186 shares worth $256K. The position accounts for 0.02% of the portfolio, ranked #303.

SYM Financial Corp first reported a position in BIIB in Q3 2025 and has held it in 3 quarters since. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • SYM Financial Corp held 1,186 shares of Biogen worth $256K as of Q2 2026.
  • SYM Financial Corp bought 36 Biogen shares in Q2 2026, an estimated $6.89K.
  • Biogen made up 0.02% of SYM Financial Corp's portfolio in Q2 2026, its #303 holding.
  • SYM Financial Corp first reported a position in Biogen in Q3 2025 and has held it in 3 quarters since.
  • 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on SYM Financial Corp's 13F filing for Q2 2026, filed 4 Aug 2026.